Triple-Action Metabolic Compound

GLP-3RT

Size: 10MG

Select product size
GLP-3RT GREYLINE research vial
$139.982 vials · $69.99 per vial
Select quantity tier
2
VisaDiscoverMastercardAmerican ExpressApple PayBitcoin

For research use only. Not for human or veterinary use.

Product Description

GLP-3RT is presented as an investigational single-peptide agonist of the GIP, GLP-1, and glucagon receptors. Published phase 1 and phase 2 studies describe metabolic and body-weight outcomes for this three-receptor research approach, but the investigational compound is not an FDA-approved drug. Public records do not authenticate the contents, salt form, purity, or strength of this specific catalog vial, so lot identity remains unverified until supported by matching analytical documentation.

Certificate of Analysis

Lot-specific analytical results and downloadable documentation

LOT-SPECIFICNO DOCUMENT ON FILE
—Verified purity resultCOA unavailable
Product
GLP-3RT
Lot number
—
Test date
—
Purity (HPLC)
—
Identity
—
Net content
—
Sterility
—
Endotoxin
—

Related research compounds

Third-party tested
Cagrilintide research vial

Cagrilintide

From $69.99

Metabolic Research Peptide

Third-party tested
5-Amino-1MQ research vial

5-Amino-1MQ

From $49.99

Metabolic Compound

Third-party tested
MOTS-C research vial

MOTS-C

From $39.99

Metabolic Peptide

Third-party tested
BPC-157 research vial

BPC-157

From $39.99

Cellular Peptide

Third-party tested
GHK-CU research vial

GHK-CU

From $29.99

Dermal Compound

Third-party tested
Tesamorlin research vial

Tesamorlin

From $69.99

Secretagogue Peptide

Third-party tested
TB-500 research vial

TB-500

From $39.99

Cellular Peptide

Third-party tested
Melanotan II research vial

Melanotan II

From $29.99

Research Peptide

Compound Information

Technical specifications

Molecular Profile

What is GLP-3RT?

Type
Acylated triple-receptor peptide agonist (GIPR/GLP-1R/GCGR)
CAS number
2381089-83-2
Molecular weight
4731.36 g/mol
Amino acids
39-residue modified peptide
Molecular formula
C221H342N46O68
PubChem: GLP-3RT-related compound record
Storage Requirements

Stability Information

Formulation-specific stability unknownKeep sealed and dryProtect from light
Lyophilized / unopenedNo product-specific shelf life supplied; follow a qualified laboratory SOP.
Reconstituted / in solutionNo authoritative hold time supplied; use a validated laboratory protocol.

The printed vial strength does not establish identity, salt form, purity, sterility, or stability.

Sources & References

Peer-reviewed and authoritative records

Cell Metabolism

Primary research

Triple-receptor agonist discovery and early clinical proof of concept

Summary: Primary research on GIP, GLP-1, and glucagon receptor agonism in metabolic models and early human evaluation.

2022·DOI: 10.1016/j.cmet.2022.07.013

Coskun T, Urva S, Roell WC, et al.

View Source

The Lancet

Primary research

Triple-receptor agonist in type 2 diabetes: phase 1b dose-escalation trial

Summary: Randomized, double-blind, placebo-controlled early clinical study of multiple ascending doses.

2022·DOI: 10.1016/S0140-6736(22)02033-5

Urva S, Coskun T, Loh MT, et al.

View Source

The New England Journal of Medicine

Primary research

Triple-hormone-receptor agonist for obesity: phase 2 trial

Summary: Phase 2 clinical study evaluating body-weight outcomes and safety in adults with obesity.

2023·DOI: 10.1056/NEJMoa2301972

Jastreboff AM, Kaplan LM, Frías JP, et al.

View Source

The Lancet

Primary research

GIP, GLP-1, and glucagon receptor agonist in type 2 diabetes: phase 2 trial

Summary: Randomized, double-blind, placebo- and active-controlled clinical study in people with type 2 diabetes.

2023·DOI: 10.1016/S0140-6736(23)01053-X

Rosenstock J, Frias JP, Jastreboff AM, et al.

View Source

ClinicalTrials.gov

Clinical trial registry

Triple-receptor agonist study in participants with obesity or overweight (NCT04881760)

Summary: Official trial-registry record for the phase 2 study in participants with obesity or overweight.

2021

Eli Lilly and Company

View Source

Important Research Notice

Not for human consumption. This product is sold exclusively for laboratory, analytical, and educational research purposes. It is not intended to diagnose, treat, cure, or prevent any disease.

Research information presented on this page is provided for educational reference and should not be interpreted as medical advice or as a product claim.

By purchasing this product, the customer confirms that it will be handled and used only by qualified individuals in accordance with all applicable laws and laboratory procedures.

Premium research peptides,
refined for modern researchers.

High purity. Verified quality. Trusted by researchers worldwide.

Shop Now